Clinical Trial Update: Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma [Phase 2]

View source ↗

Summary

This document reports that a Phase 2 trial of autologous stem cell transplantation with maintenance therapy for multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Virginia | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED